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Abstract
Background: Industry standards provide rigorous descriptions of required data presentation, with the aim of
ensuring compatibility across different clinical studies. However despite their crucial importance, these standards
are often not used as expected in the development of clinical research. The reasons for this lack of compliance
could be related to the high cost and time-intensive nature of the process of data standards implementation. The
objective of this study was to evaluate the value of the extra time and cost required for different levels of data
standardisation and the likelihood of researchers to comply with these levels. Since we believe that the cost and
time necessary for the implementation of data standards can change over time, System Dynamics (SD) analysis was
used to investigate how these variables interact and influence the adoption of data standards by clinical
researchers.
Methods: Three levels of data standards implementation were defined through focus group discussion involving
four clinical research investigators. Ten Brazilian and eighteen American investigators responded to an online
questionnaire which presented possible standards implementation scenarios, with respondents asked to choose
one of two options available in each scenario. A random effects ordered probit model was used to estimate the
effect of cost and time on investigators’ willingness to adhere to data standards. The SD model was used to
demonstrate the relationship between degrees of data standardisation and subsequent variation in cost and time
required to start the associated study.
Results: A preference for low cost and rapid implementation times was observed, with investigators more likely to
incur costs than to accept a time delay in project start-up. SD analysis indicated that although initially extra time
and cost are necessary for clinical study standardisation, there is a decrease in both over time.
Conclusions: Future studies should explore ways of creating mechanisms which decrease the time and cost
associated with standardisation processes. In addition, the fact that the costs and time necessary for data standards
implementation decrease with time should be made known to the wider research community. Policy makers
should attempt to match their data standardisation policies better with the expectations of researchers.
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The adoption of information technology by the medical
community is increasing, with patient records that used
to be stored in different locations and in both paper and
electronic formats, now gathered together as Electronic
Medical Records (EMR) [1]. Besides the potential bene-
fits for patients and providers, such as fewer medical
errors and improved quality of care [2], there are also
benefits for health care researchers, such as improving
the understanding of clinical practice and outcome
assessment [1]. However certain obstacles currently
impair the achievement of these benefits. While a stan-
dardised system exists for coding diagnosis and proce-
dure, medical terminology and clinical data such as
labels used in laboratory tests and units of measurement
are not always standardised and are therefore not easily
accessible in discrete fields within the EMR [1].
In the academic research field there has also been an
attempt to automate the clinical trial process and
decrease the use of multi-part paper case report forms,
leading to an increasing use of electronic data capture
(EDC) tools. However, the rate of adoption has been
relatively slow and such tools are being used in only
~30% of clinical studies, with many of those still retain-
ing a paper back-up [3]. Furthermore, these tools still
require improvement, since many are not yet ready to
connect to or share data with other applications within
the clinical trial process [4].
Millions of biomedical research datasets are generated
every year, potentially yielding critical information
which could significantly influence the way healthcare is
practised. However this potential is often not realised,
because different datasets typically use different ‘term’
definitions (definitions of variables in a database) [5],
which prevents them from being integrated into larger
datasets. Large integrated datasets are crucial because
they have the statistical power necessary to confidently
generalise findings from a sample to a wider population.
Data become much easier to handle if variables are
referred to by the same term across different databases
[6]. Data standards provide a rigorous description of
data representation [7], allowing cooperation between
researchers through the exchange of ideas and data [8].
Consistency in variable naming not only aids the inte-
gration of databases but also their analysis. This ensures
compatibility across different clinical studies. The con-
cept of standardised data includes the specification of
data fields (variables) as well as value sets (codes) that
encode data within these fields [9]. Despite their crucial
importance, until now data standards have not been
extensively used in clinical research [10].
Although the reasons for this lack of compliance are
not clear, the cost and time-intensive nature of data
standards implementation could be responsible. A study
of primary care practices showed that despite the fact
that many participants could see the motivation for and
anticipated benefits related to data sharing, such as sav-
ings from improved coding, more efficient workflow for
ancillary staff (e.g. laboratory results can be sent directly
to a patient’s practice EMR) and even the altruistic goal
of improving public health, costs were identified as a
significant barrier to health information exchange [11],
and could be a factor related to the lack of compliance
with data standards. However, in the industrial setting it
has been demonstrated that data standards implementa-
tion, when applied in the start-up stage, can save not
only money but also time in the long term [12].
In the initial phase of study, time and funding are
required for the implementation of data standards.
Despite the fact that this investment will pay for itself in
the long term, it is feasible to believe that researchers
would be less likely to make the effort to standardise
their CRFs or EMRs. Nevertheless, the lack of quantifi-
cation prevents adequate modelling of the minimum
level of maturity required for widespread adherence
among clinical researchers.
The economic aspects of using data standards from
the perspective of bio-pharmaceutical companies, tech-
nology providers and contract research organisations
have previously been studied [12]. To date, however,
there has been no investigation of clinical researchers’
willingness to spend the additional money and time
needed for the implementation of these standards.
Therefore, the objective of this study was to evaluate
the value of the extra time and cost required for differ-
ent levels of data standards maturity and the corre-
sponding likelihood of researchers to comply with these
standards.
Methods
Study sample
A list of ten investigators from the Hospital Alemão
Oswaldo Cruz, Brazil and eighteen from Duke
University Hospital, USA, was obtained from the admin-
istration department of each of these institutions.
Professional clinical researchers who have taken part in
at least one multi-site clinical trial participated in this
study. Investigators were contacted by email and invited
to respond to an online questionnaire offered through
DADOS-Survey [13], a web application specifically
designed for conducting surveys compliant with interna-
tional survey guidelines [14]. Because the survey was
anonymous, the project was exempt from informed con-
sent, but nevertheless, approval from the Institutional
Review Board was obtained from both participating
institutions.
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The study began with a slide presentation on data stan-
dards implementation for all study participants. The
presentation explained the advantages of data standards,
such as the ability to merge data from the current study
with other studies or administrative data, as well as the
limitations of data standards, which included the
increased cost and time necessary for project comple-
tion. Participants were presented with different examples
of the cost and time necessary for study initiation using
data standards, along with three possible data standards
implementation levels, namely lite, intermediate and full
(Table 1). A lite implementation level was defined as
one involving low cost, a faster implementation time
and a low level of standardisation. Intermediate imple-
mentation was defined as having mid-range cost and
time for completion, as well as a greater level of stan-
dardisation. Full implementation was defined as one of
high cost, a slower rate of completion and the highest
level of standardisation.
Since data standardisation can involve a variety of dif-
ferent steps, there is no common consensus regarding
the explicit value of the ‘average’ amount of time and
money spent on its implementation within different
types of clinical research study. Therefore, we formed a
focus group consisting of four clinical research investi-
gators, who through a Delphi method [15] agreed time
and dollar values that would be reasonable for the
implementation of data standards in a medium-sized
study. All investigators had experience of at least four
previous clinical registries and experience of participat-
ing in at least one programme of data standardisation.
After three rounds of the Delphi survey, the values (pre-
sented in Table 1) were agreed upon by all but one
panel member (who disagreed on the amount of time
required for the full protocol).
Twenty different data standardisation scenarios were
identified for analysis (Table 2), after those that might
generate contradiction were discounted. This arrange-
ment resembled that of a conjoint analysis, but since
only a small sample of researchers was available no
modelling was performed. Instead, descriptive analysis
was conducted so that the results could be fed into the
SD model. Study participants were presented with these
possible scenarios and were asked to choose one of two
options presented in each scenario, which they would
consider implementing in one of the clinical trials that
they usually performed (constituting the average trial
size and complexity for the group).
Once the participants had completed the surveys, data
were extracted by the project coordinator and only
questionnaires that were internally consistent were
selected for statistical analysis.
Statistical analysis
In order to estimate the effect of cost and time on
investigators’ willingness to adhere to data standards in
their CRFs, a random effects ordered probit model was
used [16], with change from current scenario taken as
the dependent variable. In each model, dummy variables
were created for the level of standards implementation
(intermediate = 1, full = 2), additional cost of study (US
$10,000, $40,000 for American researchers or R$5,000,
R$10,000 for Brazilian researchers. Both currencies were
included to allow for comparison between data collected
in Brazil and the US) and additional time before initia-
tion of study (one or four additional months).
Table 1 Possible data standards implementation levels -
time and money parameters for defining the different
levels of implementation
Attributes Levels
Additional cost of study no additional cost, $10,000, $40,000 for US
or R$5,000, R$20,000 for Brazil
Standards implementation LITE, INTERMEDIATE, FULL
Additional time before
initiation of study
no additional time, 1 month, 4 months
Table 2 The 20 possible scenarios of data standard
implementation presented to the participants in
the study
(A) Current (B) Alternative
Standards
Implementation
Standards
Implementation
choice 1 LITE OR INTERMEDIATE
choice 2 LITE OR INTERMEDIATE
choice 3 LITE OR INTERMEDIATE
choice 4 LITE OR FULL
choice 5 LITE OR FULL
choice 6 LITE OR FULL
choice 7 LITE OR FULL
choice 8 LITE OR INTERMEDIATE
choice 9 LITE OR INTERMEDIATE
choice 10 LITE OR INTERMEDIATE
choice 11 LITE OR INTERMEDIATE
choice 12 LITE OR FULL
choice 13 LITE OR FULL
choice 14 LITE OR FULL
choice 15 LITE OR INTERMEDIATE
choice 16 LITE OR INTERMEDIATE
choice 17 LITE OR INTERMEDIATE
choice 18 LITE OR FULL
choice 19 LITE OR FULL
choice 20 LITE OR FULL
Participants were asked to choose one from two possible data standard
implementation levels.
*Time measure in months and money measure in American dollars for
American researchers and in Brazilian reais for Brazilian researchers.
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Despite the fact that implementation time and cost
stand to increase when data standards are used in a
study, we believe that these variables can interact over
time, leading to modification of the overall behaviour of
a system - commonly referred to as dynamic behaviour.
For example, inflow and outflow of water from a bath-
tub results in the generation of dynamic behaviour over
ap e r i o do ft i m e( F i g u r e1 ) .S y s t e mD y n a m i c s( S D )a n a -
lysis was used to investigate the behaviour of variables
such as implementation time and cost over time. SD is
essentially a set of tools that help the user understand
and predict how systems (complex systems) behave over
time[17]and is graphically represented by stocks (boxes),
flows (thick arrows) and causal diagrams (thin arrows).
A stock represents elements that can be measured and
accumulated, and are regulated by the flows. A flow
determines the rate of influx to, or efflux from the
stock. Any other elements that influence the system are
represented as a variable, with these relationships repre-
sented by causal diagrams. The SD model[18]was used
to demonstrate the relationship between degrees of stan-
dardisation, cost of standardisation and time required to
start the study. The model was created with the pro-
gram Vensim PLE for Windows 5.9c [19].
Despite the fact that applying and using data stan-
dards in clinical studies can bring many advantages that
could encourage researchers to adopt their implementa-
tion, there are also many associated drawbacks that
could inhibit their use. From the survey, it was observed
that an increase in cost and time to commence a study
are unwanted aspects related to the use of data stan-
dards. Based on this information, we wanted to investi-
gate how these variables, together with the increase in
the number of standardised case report forms accumu-
lated by a researcher, interacted and behaved over time,
creating a situation that could change the researcher’s
perceptions regarding the implementation of data stan-
dards. Since SD is a set of tools used to help understand
complex systems, we chose to use this strategy to help
identify and explain the complex behaviour related to
the use of data standards by unveiling the complexity
behind its structure. We believe that by learning about
the behaviour of this complex system, the advantages
and drawbacks related the adoption of data standards
can be identified and presented to researchers, so they
can make an informed decision related to this subject.
Results
Probability of response
Probability of response results indicated a preference for
free (definitely lite) standards implementation, with
increasing probabilities of a choice of both intermediate
and full standards with respect to their implementation at
low, medium and high levels. This relationship, however,
was only significant for full vis-à-vis lite implementation
(p < 0.001), not vis-à-vis intermediate implementation
(p = 0.228) (Table 3).
The probability of response results with respect to
time also show a preference for free alternatives (defi-
nitely lite), although this was not statistically signifi-
cant compared to either intermediate or full standards
(p = 0.116 and 0.496 respectively) (Table 4).
Policy model
In our model we assume that the cost and time required
to implement any given standard level decreases with
the level of standards already accumulated. We describe
here the behaviour of three variables (number of uni-
form datasets, implementation cost and implementation
time) for a hypothetical period of five years. The degree
of standardisation, cost of standardisation and time
required to start the study were standardised on a scale
from 1 to 10, with individual beta coefficients derived
from the regression model using the normalised
variables.
The general idea behind the model is that the imple-
mentation of data standards will lead to the generation
of uniform datasets which integrate different databases,
making it possible for the researcher to work with larger
databases. This will result in higher quality research and
publication, creating the desire for more uniform data-
sets which in turn will lead to the further implementa-
tion of data standards. This causal relationship between
system variables is called a loop. In this case, the loop
leads to the growth of the system, so is known as a
reinforcing loop and is represented by the letter R in
Figure 2.
Figure 1 Illustration of dynamic behaviour.
Table 3 Probabilities in relation to cost response
STANDARDS IMPLEMENTATION
INTERMEDIATE FULL
LOW MEDIUM HIGH LOW MEDIUM HIGH
DEFINITELY LITE 0.2690 0.2871 0.2999 0.1944 0.2728 0.3152
PROBABLY LITE 0.2980 0.2801 0.2579 0.2297 0.2319 0.1871
DEFINITELY
INTERMEDIATE
0.0739 0.0641 0.0548
PROBABLY
INTERMEDIATE
0.1623 0.1341 0.1101
DEFINITELY
FULL
0.1318 0.1037 0.0679
PROBABLY FULL 0.3419 0.2048 0.000
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loop, the growth of that system would be exponential.
In a real-life scenario however, the cost and time
required for standards implementation tend to act nega-
tively, as demonstrated by our results, resulting in balan-
cing loops B1 and B2. The first balancing loop (B1)
represents the limitation caused by the additional time
needed for data standardisation before study start-up.
As a limitation it acts negatively, reducing the probabil-
ity of implementation. Note that there is a causal
relationship (represented by the arrows) between the
number of uniform datasets and the time spent on
implementation. This relationship will lead to lower
levels of implementation over time in the function of
the number of uniform datasets.
The second balancing loop (B2) represents the limita-
tion caused by the extra costs of conducting a study
involving standardised data. Here again there is a causal
relationship between implementation cost and the num-
ber of uniform datasets, leading to lower costs over time
depending on the number of datasets. In both balancing
loops (B1 and B2), standardisation always requires some
additional resource (time or money) to be consumed by
the study.
Figure 3 illustrates the behaviour of the variables
‘number of uniform datasets’, ‘time’ and ‘cost’ necessary
for standardisation, analysed over time. As can be seen
from this figure, the number of uniform datasets (green
line) exhibits slow growth initially, but then increases
slightly as a function of time and cost. The second vari-
able, additional cost to the study (red line), decreases
dramatically in the first six months because of the
implementation of the initial datasets, and continues to
drop throughout the period of analysis. The same
Table 4 Probabilities in relation to time response
PROPOSAL
INTERMEDIATE FULL
FAST MEDIUM SLOW FAST MEDIUM SLOW
DEFINITELY LITE 0.2738 0.2927 0.3048 0.2906 0.2850 0.2784
PROBABLY LITE 0.2929 0.2726 0.2476 0.1957 0.2010 0.2057
DEFINITELY
INTERMEDIATE
0.0723 0.0618 0.0519
PROBABLY
INTERMEDIATE
0.1595 0.1294 0.1042
DEFINITELY
FULL
0.0829 0.0875 0.0921
PROBABLY FULL 0.1673 0.1809 0.1955
Figure 2 System Dynamics Model.
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required for standardisation (blue line).
Discussion
In the present study, whenever possible a researcher
would prefer to implement the lowest possible level of
standards that would make them minimally compliant.
They also indicate that their preference is for a free
alternative, rather than a more expensive option. This
reflects the fact that the researchers perceive the
increased expenditure and time needed to implement
data standards as barriers to a study. Considering that
many research projects rely on limited funding, this
response could be expected. One interesting result, how-
ever, was that researchers prefer to pay rather than to
delay the beginning of a project. Therefore it is not sur-
prising that the implementation of data standardisation
may be rejected if perceived as having the potential to
delay project start-up.
Given the growth of clinical research and the corre-
sponding increase in the volume of data produced, stan-
dards that facilitate data sharing, transformation and
reuse are critical for maximising the amount of knowl-
edge that can be gained [9], as well as helping to
develop priceless repositories of knowledge [20]. In the
industrial setting, the implementation of standards at
the case report form stage of clinical trial development
enhances data quality and facilitates communication
between team members or partners [3,21]. The most
widely recognised advantages of industrial data standar-
disation are cost and time savings. For example, a stan-
dard implemented at the beginning of a study provides
greater returns on an investment and can result in
resource savings of 60% [22] for a single clinical
research study and 80% at the start-up stage [12]. Indus-
try-wide standards are also efficient and effective in
assessing the safety of new therapies [22]. According to
the Institute of Medicine, the use of standards has
helped to reduce expenditure in healthcare administra-
tion by 20 to 30% and has also yielded a cost reduction
of 35% in the pharmaceutical industry [23].
Implementation of standards has also proven to have
time-saving benefits with respect to the execution of
research. Data organised in different databases and
stored in different formats are difficult to gather and
can thus delay research activities [24], with the use of
standards helping shorten the time needed to complete
clinical trials by as much as one year [25]. Sponsors
have also been motivated to adopt standards with the
aim of realising considerable time savings in the
research process [20]. When data standards are used
there is a definite reduction in the time required to
Figure 3 Simulation.
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clean data, programme tables, lock the database after
last subject visit, train new employees and conduct regu-
latory reviews [26].
Clinical Data Acquisition Standards Harmonisation
(CDASH) is aimed at standardising the structure of a
study’s data and meta-data, promising to significantly
expedite clinical studies as well as the exchange of data
between sponsors and other participants in the process.
An analysis by Gartner Inc. [27] indicated that when
standards are implemented in the CRF development
stage of a clinical study, significant time and cost savings
may be achieved [21]. According to a collaboration
between the Clinical Data Interchange Standards Con-
sortium (CDISC) and the Health Information Manage-
ment Systems Society (HIMSS), the process of enabling
data to be entered only once in satisfying both the
patient healthcare record and clinical research protocol
requirements will save money and time, as well as
enhancing data quality [4].
All the studies cited above indicate savings of time
and cost obtained in an industrial setting. To the best of
our knowledge, estimates of the amount of time and/or
money necessary for the implementation of data stan-
d a r d i s a t i o ni na na c a d e m i ce n v i r o n m e n th a v en o tb e e n
available until now. Since this sort of research tends to
be characterised by reduced budgets and personnel
compared with that developed by large pharmaceutical
companies, such information must be provided for
researchers so they can evaluate the adoption of stan-
dards specific to their research context. In the present
study, the time and cost necessary for implementing
data standardisation were analysed from the perspective
of academic research. This is in contrast with investiga-
tions carried out by CDISC, who looked at the problem
from an industrial perspective. In this context standardi-
sation is often implemented upfront before the study is
carried out, with the authors predicting cost savings as a
result[3,12]. The objective of the survey performed in
this study was to provide clinical researchers with para-
meters of the cost and time necessary to standardise a
clinical trial in its initial phase of study.
T oo u rk n o w l e d g e ,S Da n a l y s i sh a sn o tb e e nu s e dt o
analyse the use of data standards by clinical researchers
u n t i ln o w .S Da n a l y s i so ft h ev a r i a b l e s‘number of uni-
form datasets’, ‘implementation cost’ and ‘implementa-
tion time’ indicated that in the initial phase of clinical
study, both the extra time and cost necessary to imple-
ment data standardisation can act as a deterrent to their
implementation. However over time, the number of uni-
form datasets accumulated by the researcher increases,
leading to a decrease in the cost and time necessary for
standardisation. It should be noted that this information
was not available to the researchers at the moment they
were asked to choose between levels of standardisation,
although they were informed of the general advantages
of using standardised data. This may represent a limita-
tion of the present study, since it is possible that
researchers would have made a different selection
regarding the level of standardisation if they had been
presented with this information and as such should be
considered in future studies. Another limitation of the
present study is that the small sample size precluded
further analysis.
Given the difficulty of quantifying most of the ele-
ments involved in this complex system, a very simple
model was created here in order to better understand
the relationship between the elements of cost and time
necessary for the implementation of data standardisa-
tion. As such, it should be pointed out that the SD
model and simulations are not intended to act as a fore-
cast, with the simulations created for hypothetical sce-
narios. While the developed model may be useful for
explaining why standardisation is important, further stu-
dies are necessary in order to better understand this
problem.
In this study, values of the time and money needed to
implement data standards were based on a consensus
amongst researchers; nevertheless, variations could
occur. The amount of money defining each level (lite,
intermediate or low) was defined in different currencies
(American dollars for American researchers and Brazi-
lian reais for Brazilian researchers) and only numerical
values were used to determine levels of standardisation
(lite, intermediate, full). In the statistical analysis, differ-
ent currencies were not considered but rather only the
levels of standardisation, so this should not have influ-
enced the results.
The focus of the present work was to investigate the
cost of and willingness for data standards implementa-
tion within a clinical trial design study, in which the
researcher does not have the prior intention of using
their data for research collaboration. In this respect, it is
important to consider whether the costs associated with
study standardisation will differ when the process is car-
ried out prior to or after the completion of a study.
Also, the motivation to standardise a study of a
researcher who foresees collaboration and data sharing
with another group, is definitely different from that
observed in our results, since this framework was not
considered in the survey. Lastly, our results are probably
not suitable for generalised application to other aspects
of clinical research design, for example when the imple-
mentation of standards is a required component of the
submission of research data associated with a particular
publication.
Before choosing between these levels of standardisa-
tion, researchers were informed of the advantages of
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their study. It should be borne in mind that owing to
the competitive nature of the scientific research environ-
ment and the historical culture of not sharing data, this
is not common practice amongst researchers [28]. In
addition, many researchers were and are afraid that
their findings could be stolen or misused when data are
shared [29].
Despite the fact that the investigation of this psycholo-
gical factor was not one of the initial objectives of this
study, we believe that in order to expand the use of data
standards within the scientific community, such influ-
ences must be considered and addressed. Lastly, the
advantages of research standardisation must be empha-
sised, most importantly the fact that despite the initial
investment required, researchers will actually save time
and money as they accumulate a greater number of
standardised studies. This must be made clear through-
out the community if researchers intend to take full
advantage of research data.
Conclusion
In light of the above results, we believe that the identifi-
cation of time and cost factors will allow for customisa-
tion of different approaches depending on the
researcher’s priorities. It will also allow research policy
organisations to match their data standardisation poli-
cies more accurately to the expectations of researchers.
Since the increased time and cost of starting a study
were important factors influencing researchers not to
use data standards, future studies should explore ways
of creating mechanisms which decrease the time and
cost associated with standardisation processes, thus
facilitating their implementation. Other mechanisms
should be created which increase the personal benefits
for individual researchers using standards; for example,
the increased likelihood of publication for studies in
which data standards were implemented or where data
sharing between multiple research groups occurred.
Meta-data sharing should also be encouraged, since this
should enhance data reuse and therefore indirectly
encourage standardisation, which should in turn lead to
the production of critical information benefiting health-
care research.
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